Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Knee Osteoarthritis | Study protocol

Genicular artery embolization as a novel treatment for mild to moderate knee osteoarthritis: protocol design of a randomized sham-controlled clinical trial

Authors: T. A. van Zadelhoff, A. Moelker, S. M. A. Bierma-Zeinstra, P. K. Bos, G. P. Krestin, E. H. G. Oei

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Introduction

Knee osteoarthritis is a common disease with pain as the most prevalent symptom. Previous cohort studies have shown genicular artery embolization to reduce pain symptoms in patients with mild to moderate knee osteoarthritis. Patients resistant to conservative therapy but not eligible yet for surgical treatment due to young age or comorbidities may profit from an effective and sustained pain reduction treatment. This study is a randomized sham-controlled trial to evaluate the efficacy of genicular artery embolization in patients with knee osteoarthritis.

Methods and analysis

Fifty-eight patients with mild-to-moderate knee osteoarthritis will be recruited and randomly allocated to the treatment or control group in a 1:1 ratio. Participants in the treatment group will undergo genicular artery embolization. Patients in the control group will undergo sham treatment. Outcome measurements will be assessed at baseline and after 1, 4, 8, and 12 months with questionnaires, pressure pain threshold testing, and MR imaging. The MR imaging protocol is designed to (semi)quantitatively assess osteoarthritis in the knee joint. The primary outcome is the change from baseline of the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscale after 4 months. Secondary outcomes include change in osteoarthritis-related questionnaires, pressure pain threshold, and OA-related MRI features, particularly synovitis and bone marrow lesions.

Ethics and dissemination

This trial will determine the efficacy of genicular artery embolization compared to a sham treatment. This is of importance to assess before proceeding to larger-scale efficiency studies and, ultimately, implementing this treatment into day to day clinical practice.

Trial registration

ClinicalTrials.​gov NCT03884049. Registered on 21 March 2019
Literature
1.
go back to reference Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases. 2014;73(7):1323–30.CrossRef Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases. 2014;73(7):1323–30.CrossRef
4.
go back to reference Jacobson AF, Myerscough RP, Delambo K, Fleming E, Huddleston AM, Bright N, et al. Patients’ perspectives on total knee replacement. Am J Nurs. 2008;108(5):54–63 quiz -4.CrossRef Jacobson AF, Myerscough RP, Delambo K, Fleming E, Huddleston AM, Bright N, et al. Patients’ perspectives on total knee replacement. Am J Nurs. 2008;108(5):54–63 quiz -4.CrossRef
13.
go back to reference Kolahi J, Bang H Fau-Park J, Park J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. (1600-0528 (Electronic)). Kolahi J, Bang H Fau-Park J, Park J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. (1600-0528 (Electronic)).
23.
Metadata
Title
Genicular artery embolization as a novel treatment for mild to moderate knee osteoarthritis: protocol design of a randomized sham-controlled clinical trial
Authors
T. A. van Zadelhoff
A. Moelker
S. M. A. Bierma-Zeinstra
P. K. Bos
G. P. Krestin
E. H. G. Oei
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-021-05942-x

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue